Company Analysis

Alkermes plc (ALKS)

Nasdaq: ALKS · Pharmaceutical Preparations · Dublin 4, IE · filing with the SEC since 2011
Grade6.6
◀ Past 6.8● Present 7.2▶ Future 5.4

Filings

377 filings since 2017 beside 703 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 34 days after the quarter ended. The proxy statement was last filed Apr 6, 2026.

Filings a yearinsider forms included
94891208913010491122
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest Sep 16, 2026.
Insider forms 703

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 8-K item 1.01 Major agreement signed · Current report Nov 6, 2026
Nov 3, 2026 10-Q Quarterly report Sep 30, 2026
Nov 3, 2026 8-K items 2.02, 9.01 Results released · Current report
Sep 21, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Sep 16, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Sep 14, 2026
Aug 12, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report
Aug 3, 2026 8-K/A item 5.02 Officer or director change · Current report, amended Feb 24, 2026
Jul 28, 2026 S-8 Employee stock plan registration
Jul 28, 2026 10-Q Quarterly report Jun 30, 2026
Jul 28, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 8, 2026 8-K item 1.02 Major agreement ended · Current report Jul 6, 2026
Jun 15, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
May 20, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 13, 2026 DEFA14A Extra proxy material
May 12, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
May 5, 2026 10-Q Quarterly report Mar 31, 2026
May 5, 2026 8-K items 2.02, 9.01 Results released · Current report
May 1, 2026 8-K/A item 9.01 Financial statements and exhibits · Current report, amended Feb 12, 2026
Apr 28, 2026 SCHEDULE 13G Large holder notice
Apr 28, 2026 SCHEDULE 13G Large holder notice
Apr 6, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 6, 2026 DEFA14A Extra proxy material
Apr 6, 2026 DEF 14A Proxy statement May 20, 2026
Mar 27, 2026 PRE 14A Preliminary proxy statement May 20, 2026
Mar 26, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 25, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Feb 24, 2026
Feb 25, 2026 10-K Annual report Dec 31, 2025
Feb 25, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 17, 2026 SCHEDULE 13G Large holder notice
Jan 12, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jan 6, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Nov 19, 2025 8-K items 1.01, 2.03, 7.01, 9.01 Major agreement signed; New debt or obligation taken on; Investor disclosure (Regulation FD) · Current report Nov 18, 2025
Nov 12, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Nov 10, 2025 SCHEDULE 13G Large holder notice
Oct 28, 2025 10-Q Quarterly report Sep 30, 2025
Oct 28, 2025 8-K items 2.02, 9.01 Results released · Current report
Oct 22, 2025 8-K items 1.01, 2.02, 2.03, 7.01, 9.01 Major agreement signed; Results released; New debt or obligation taken on; Investor disclosure (Regulation FD) · Current report
Sep 12, 2025 8-K items 1.01, 8.01 Major agreement signed; Other event · Current report Aug 15, 2025
40 of 377 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ALKS · research, not advice